A Retraction of the Original Research Article
Exploration of multiple signaling pathways through which sodium tanshinone IIA sulfonate attenuates pathologic remodeling experimental infarction
by Mao S, Vincent M, Chen M, Zhang M and Hinek A (2019) . Front. Pharmacol. 10:779. doi: 10.3389/fphar.2019.00779
The journal retracts the 12 July 2019 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication was identified between Figure 6B and 7B. Some panels of Figure 3C, 6B and 9B were also found to be published in other articles.
The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable, and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. Author MV agrees to this retraction. Authors SM, MC, MZ and AH did not respond to correspondence regarding this retraction.
Frontiers would like to thank the users on PubPeer for bringing the published article to our attention.
Citation: Frontiers Editorial Office (2025) Retraction: Exploration of multiple signaling pathways through which sodium tanshinone IIA sulfonate attenuates pathologic remodeling experimental infarction. Front. Pharmacol. 16:1575629. doi: 10.3389/fphar.2025.1575629
Received: 12 February 2025; Accepted: 12 February 2025;
Published: 19 February 2025.
Approved by:
Michael Heinrich, University College London, United KingdomCopyright © 2025 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==